Loading…
Vor Biopharma Inc. is projected to rise to $20.38 by 2027, a +31% move from its current price of $15.52. VOR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $14.89 | $15.54 | $16.22 | +0.13% |
| May 30 | $14.65 | $15.56 | $16.53 | +0.27% |
| May 31 | $14.48 | $15.58 | $16.77 | +0.40% |
| Jun 1 | $14.33 | $15.60 | $16.99 | +0.53% |
| Jun 2 | $14.21 | $15.62 | $17.18 | +0.67% |
| Jun 3 | $14.10 | $15.64 | $17.36 | +0.80% |
| Jun 4 | $14.00 | $15.67 | $17.53 | +0.94% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.00 | $15.67 | $17.53 | +0.94% |
| Week 2 | $13.49 | $15.81 | $18.54 | +1.88% |
| Week 3 | $13.13 | $15.96 | $19.40 | +2.84% |
| Week 4 | $12.86 | $16.11 | $20.18 | +3.80% |
| Week 5 | $12.64 | $16.26 | $20.92 | +4.78% |
| Week 6 | $12.46 | $16.41 | $21.63 | +5.76% |
| Week 7 | $12.30 | $16.57 | $22.32 | +6.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vor Biopharma Inc. is a clinical-stage biopharmaceutical company focused on the development of a novel therapy in the treatment of autoimmune diseases.
It offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products.
The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Vor Biopharma Inc. (VOR) is a healthcare company with a current price of $15.52 and a market cap of $840.96M.
It ranks 2633 in market position by rank.
The forecast horizon shows upside potential beyond the current price, with the 2026 avg at $15.52 and 2027-2050 forecasts rising to $23.72 by 2030 and $139.10 by 2050.
Maximum forecast values rise to $25.31 in 2026, $38.54 in 2030, and $310.96 in 2050, with sentiment moving from NEUTRAL in 2026 to BULLISH thereafter; ROI grows from 0 in 2026 to 796.3 in 2050.
A major floor 22.4% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 11.1% above — a clean break opens room to run.
A major ceiling 22.2% above — clearing it would confirm fresh momentum.
Key VOR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VOR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.91 | Buy | $14.88 | Buy |
| MA 10 | $14.84 | Buy | $14.96 | Buy |
| MA 20 | $15.17 | Buy | $15.08 | Buy |
| MA 50 | $15.03 | Buy | $15.05 | Buy |
| MA 100 | $14.61 | Buy | $15.61 | Sell |
| MA 200 | $20.05 | Sell | $17.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.56 | Neutral |
| Stoch RSI (14) | 48.82 | Neutral |
| CCI (20) | 26.88 | Neutral |
| Williams %R (14) | -54.92 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -8.38 | Sell |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 45.08 | Neutral |
| TRIX (15) | -0.02 | Sell |
| Awesome (5,34) | -0.29 | Sell |
| Ultimate (7,14,28) | 54.92 | Neutral |
| Momentum (10) | -0.95 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 14.69 | Buy |
| ADX (14) | 10.37 | Neutral |
| ATR (14) | 0.64 | Info |
The 30-day technical picture is BULLISH.
Key indicators show RSI14 at 50, with SMA50 at $15.03 and SMA200 at $20.05. Immediate support is at $13.81 and resistance at $17.25.
The 30-day trading range runs from $11.72 to $20.55.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.58 | $15.52 | $25.31 | 0% | Neutral | |
| $15.29 | $20.38 | $29.22 | +31% | Bullish | |
| $16.52 | $23.04 | $34.78 | +48% | Bullish | |
| $15.52 | $22.49 | $35.34 | +45% | Bullish | |
| $15.81 | $23.72 | $38.54 | +53% | Bullish | |
| $19.56 | $30.29 | $50.68 | +95% | Bullish | |
| $22.55 | $36.00 | $61.81 | +132% | Bullish | |
| $25.90 | $42.56 | $74.81 | +174% | Bullish | |
| $24.97 | $42.19 | $75.76 | +172% | Bullish | |
| $21.50 | $37.33 | $68.37 | +141% | Bullish | |
| $33.94 | $66.88 | $132.99 | +331% | Bullish | |
| $62.59 | $139.10 | $310.96 | +796% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $10.58 | $15.52 | $18.45 | +0.00% |
| June 2026 | $14.14 | $16.81 | $20.61 | +8.32% |
| July 2026 | $14.55 | $17.53 | $21.93 | +4.26% |
| August 2026 | $14.43 | $17.57 | $22.33 | +0.23% |
| September 2026 | $15.01 | $18.44 | $23.73 | +4.95% |
| October 2026 | $15.77 | $19.52 | $25.42 | +5.89% |
| November 2026 | $15.51 | $19.34 | $25.43 | -0.95% |
| December 2026 | $15.19 | $19.06 | $25.31 | -1.41% |
Click any year to see its month-by-month VOR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Vor Biopharma Inc.'s 2026 outlook centres on $15.52, within a $10.58 to $25.31 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, VOR could reach as high as $29.22, with a base case around $20.38 and support toward $15.29 — roughly +31% from $15.52. Buyers look set to stay in control over this stretch.
Expect VOR to range from $16.52 to $34.78 through 2028. The $23.04 average target implies a +48% move from current prices. That is up +13% on the projected 2027 average. Momentum favours further upside here.
The VOR price prediction for 2029 points to an average of $22.49 (low $15.52, high $35.34) — a potential gain of +45% on today's $15.52. Buyers look set to stay in control over this stretch.
In 2030, VOR is projected to trade between $15.81 and $38.54, averaging $23.72 — a potential gain of +53% from today's $15.52. That is up +5% on the projected 2029 average. Momentum favours further upside here.
Vor Biopharma Inc.'s 2031 outlook centres on $30.29, within a $19.56 to $50.68 range. That is up +28% on the projected 2030 average. That marks a +95% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, VOR could reach as high as $61.81, with a base case around $36.00 and support toward $22.55 — roughly +132% from $15.52. Momentum favours further upside here.
Expect VOR to range from $25.90 to $74.81 through 2033. The $42.56 average target implies a +174% move from current prices. That is up +18% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The VOR price prediction for 2034 points to an average of $42.19 (low $24.97, high $75.76) — a potential gain of +172% on today's $15.52. Momentum favours further upside here.
In 2035, VOR is projected to trade between $21.50 and $68.37, averaging $37.33 — a potential gain of +141% from today's $15.52. That is -12% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Vor Biopharma Inc.'s 2040 outlook centres on $66.88, within a $33.94 to $132.99 range. That is up +79% on the projected 2035 average. That marks a +331% change versus current levels. Momentum favours further upside here.
By 2050, VOR could reach as high as $310.96, with a base case around $139.10 and support toward $62.59 — roughly +796% from $15.52. Buyers look set to stay in control over this stretch.
Investing $1,000 in VOR today (≈ 64.43299 VOR) could be worth
$8,962.57
+$7,962.57 (+796%) by 2050 · US Dollar
Based on the average projected VOR price of $139.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VORwould be worth at today's price.
$1,000 invested in VOR on May 27, 2025 (≈ 287.35632 VOR) would be worth
$4,459.77
+$3,459.77 (+346.0%) today · 4.46× · US Dollar
Based on a VOR entry price of $3.48 vs. today's $15.52.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.55 | $998.07 | -0.2% |
| 1 month ago | $14.12 | $1,099.15 | +9.9% |
| 3 months ago | $15.9 | $976.1 | -2.4% |
| 6 months ago | $8.33 | $1,863.15 | +86.3% |
| 1 year ago | $3.48 | $4,459.77 | +346.0% |
| All time (5.0y) ago | $411 | $37.76 | -96.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VOR forecast.
Our base-case forecast reaches $31.00 around 2032.
Implied market cap at $31.00: $1.68B
The multi-year forecast shows a bullish trajectory with expected price growth across years.
In 2026, avg is $15.52, min $10.58, max $25.31, ROI 0, sentiment NEUTRAL.
In 2030, avg is $23.72, min $15.81, max $38.54, ROI 52.8, sentiment BULLISH.
In 2040, avg is $66.88, min $33.94, max $132.99, ROI 330.9, sentiment BULLISH.
In 2050, avg is $139.10, min $62.59, max $310.96, ROI 796.3, sentiment BULLISH.
Tap a question to reveal the answer.
2029–2030 data show min $15.81, avg $23.72, max $38.54; ROI 52.8; sentiment BULLISH.
Forecasts indicate bullish sentiment from 2027 onward with rising averages and ROI into 2030 and beyond; 2026 is Neutral with avg $15.52.
Yes. The 2040 max is $132.99 and the 2050 max is $310.96, indicating the potential to exceed $100 by 2040 and especially by 2050.
Current price is $15.52 and market cap is $840.96M.
The 30-day range is $11.72 to $20.55.
Vor Biopharma Inc. Community Discussion
0Share your Vor Biopharma Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.